Related Experiment Videos

Characterization of irritable bowel syndrome and constipation in children with allergic diseases

Carlo Caffarelli1, Alessandra Coscia, Francesco Baldi

  • 1Dipartimento dell'Età Evolutiva, Clinica Pediatrica, Università di Parma, Via Gramsci 14, 43100 Parma, Italy. carlo.caffarelli@unipr.it

Insights

Allergic children do not show higher rates of constipation or irritable bowel syndrome (IBS). However, in allergic children with positive food allergy tests, IBS symptoms warrant attention.

Area of Science:

  • Pediatrics
  • Allergology
  • Gastroenterology

Background:

  • Allergy is implicated in the development of irritable bowel syndrome (IBS) and constipation.
  • The relationship between allergic conditions and functional gastrointestinal disorders in children requires further investigation.

Purpose of the Study:

  • To determine if children with allergies are more susceptible to constipation or IBS.
  • To explore the association between allergic sensitization and functional gastrointestinal disorders in pediatric outpatients.

Main Methods:

  • A multicenter study comparing allergic children (n=196) with non-allergic controls (n=127), aged 3-13 years.
  • Assessment of IBS and constipation using Rome criteria questionnaires.
  • Skin prick tests (SPT) for food and aeroallergens, and evaluation of self-reported food reactions.

Main Results:

  • No significant difference in the prevalence of IBS (6.6% vs. 6.3%) or constipation between allergic and non-allergic children.
  • Positive SPTs to foods and self-reported food reactions were associated with IBS in the allergic group.
  • No increased comorbidity of constipation was observed in allergic children.

Conclusions:

  • Routine evaluation for constipation comorbidity is not necessary in children with allergies.
  • In allergic children with positive SPTs to foods, attention should be directed towards potential IBS symptoms.

Related Concept Videos

Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.